title: Impact of introducing near patient testing for standard investigations in general practice.
abstract: OBJECTIVE
  To assess the clinical and economic impact of surgery based near patient testing in general practice for six commonly used biochemical and bacteriological tests.
  
  
  METHODS
  After four months' monitoring, equipment for two bacteriological and four biochemical tests was introduced without cost into 12 practices using a crossover design. Structured request forms were used to monitor laboratory investigations.
  
  
  METHODS
  12 general practices in west midlands and south west Thames with list sizes above 9000.
  
  
  METHODS
  Investigation rates per 1000 consultations. Changes from baseline rates. Reasons for requesting investigations and provisional diagnoses. Cost per test and sensitivity of costs to rate of use.
  
  
  RESULTS
  Investigation rates for the six tests rose by 16.5% (from 78.6/1000 consultations to 91.6/1000) when equipment was available in the surgery and reverted to baseline rates when it was withdrawn. The average weekly number of tests when equipment was available ranged from 0.5 to 10.5 (mean 9.0). Cholesterol tests were used as an addition to laboratory testing, usually for screening. Midstream urine analysis was often done in the surgery instead of in the laboratory, although 30% of samples were tested by both methods. Doctors' reasons for investigation and conditions tested were largely unaffected by availability of surgery tests. Costs for surgery tests were higher for all tests except midstream urine.
  
  
  CONCLUSIONS
  Availability of surgery based testing increased the number of tests performed. It was cost effective only for midstream urine analysis.
authors.affiliation: Division of General Practice and Primary Care, St George's Hospital Medical School, London.
authors.forename: E
authors.initials: E
authors.lastname: Rink
authors.forename: S
authors.initials: S
authors.lastname: Hilton
authors.forename: A
authors.initials: A
authors.lastname: Szczepura
authors.forename: J
authors.initials: J
authors.lastname: Fletcher
authors.forename: B
authors.initials: B
authors.lastname: Sibbald
authors.forename: C
authors.initials: C
authors.lastname: Davies
authors.forename: P
authors.initials: P
authors.lastname: Freeling
authors.forename: J
authors.initials: J
authors.lastname: Stilwell
mesh_terms: D002784:Cholesterol / Q000097:blood; D004796:Clinical Enzyme Tests; D003362:Cost-Benefit Analysis; D003657:Decision Making; D003955:Diagnostic Tests, Routine / Q000191:economics / Q000706:statistics & numerical data*; D004739:England; D005194:Family Practice / Q000191:economics*; D005260:Female; D017048:Health Care Costs / Q000706:statistics & numerical data*; D006403:Hematologic Tests; D006801:Humans; D016482:Urinalysis; D014626:Vaginal Smears
chemical_list: D002784:Cholesterol